(19)
(11) EP 1 318 772 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
01.02.2006 Bulletin 2006/05

(45) Mention of the grant of the patent:
30.11.2005 Bulletin 2005/48

(21) Application number: 01977156.7

(22) Date of filing: 24.09.2001
(51) International Patent Classification (IPC): 
A61F 2/06(1985.01)
(86) International application number:
PCT/US2001/029814
(87) International publication number:
WO 2002/024113 (28.03.2002 Gazette 2002/12)

(54)

INTRAVASCULAR STENT

INTRAVASKULÄRER STENT

STENT INTRAVASCULAIRE

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 23.09.2000 US 235167 P

(43) Date of publication of application:
18.06.2003 Bulletin 2003/25

(60) Divisional application:
05018644.4 / 1611867

(73) Proprietor: Boston Scientific Scimed, Inc.
Maple Grove, MN 55311 (US)

(72) Inventor:
  • Jang, G. David
    Redlands, CA 92374 (US)

(74) Representative: Hauck, Graalfs, Wehnert, Döring, Siemons 
Neuer Wall 41
20354 Hamburg
20354 Hamburg (DE)


(56) References cited: : 
WO-A-99/15107
WO-A-99/40876
 WO-A-99/38457
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).